Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers in Giant Cell Arteritis
NCT02844023Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Jan 2015
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Biomarkers's serum sampling at 3 minutes. Started Jan 2015; status: terminated.
Beyond the preview
Go deeper on NCT02844023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844023.